Printer Friendly

OXFORD GLYCOSYSTEMS AND THE UNIVERSITY OF OXFORD DISCOVER A BREAKTHROUGH IN CARBOHYDRATE SEQUENCING

 OXFORD GLYCOSYSTEMS AND THE UNIVERSITY OF OXFORD
 DISCOVER A BREAKTHROUGH IN CARBOHYDRATE SEQUENCING
 OXFORD, England, Oct. 12 /PRNewswire/ -- Researchers at Oxford GlycoSystems (OGS) and the University of Oxford have developed a revolutionary system that allows the systematic sequencing of oligosaccharide molecular structures, commonly known as complex carbohydrates. The invention introduces a technology that uses arrays of enzymes in mathematically determined mixes and relies on sophisticated software algorithms. Research into these molecules is giving new insights into diseases such as arthritis, asthma and AIDS.
 "The entire field of biology revolves around identifying the connection between the structure of molecules and their function," said Dale Pfost, Ph.D., president and CEO of OGS. "Until now there has been no easy means to determine the structure of oligosaccharides, one of the major classes of molecules."
 Studies authored by OGS and Oxford University recently published in the Proceeding of the National Association of Science (PNAS, Volume 89) and the journal Nature (Volume 358), "represent an intellectual and technological breakthrough that will lead to a new generation of instrumentation for the Life Sciences," said Professor Raymond Dwek of Oxford University and the Director of its Glycobiology Institute.
 Patents on the new technology are pending in several countries. OGS has exclusive rights from Oxford University to the technology.
 "Within the next year, we will be announcing a new instrument which uses this sequencing technology to complement our first two systems: GlycoPrep(TM) 1000, the preparation system, and GlycoMap(TM) 1000, the profiling system," said Raj Parekh, vice president of Research at OGS.
 OGS, based in Oxford, England, is the leading supplier of glycobiology-related research tools for the Life Sciences. OGS, a privately owned company, offers the most extensive range of carbohydrate products and services available from a single supplier including instrumentation, custom synthesis, contract analysis and more than 250 biochemical compounds.
 -0- 10/12/92
 /CONTACT: Dale R. Pfost, Ph.D., president and CEO of Oxford GlycoSystems, 011-44-235-553066, or Georgina Ferry of University of Oxford, 011-44-865-278181, or Anthony J. Russo, Ph.D., of Noonan/Russo Communications, 212-979-9180, for Oxford GlycoSystems/ CO: Oxford GlycoSystems ST: IN: MTC SU:


SH-OS -- NY013 -- 8764 10/12/92 09:38 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 12, 1992
Words:360
Previous Article:U.S. ROBOTICS ANNOUNCES SHARED ACCESS MODEM SHARING KIT VERSION 1.5
Next Article:DOW CORNING THIRD-QUARTER FINANCIAL RESULTS REPORTED
Topics:


Related Articles
OXFORD GLYCOSYSTEMS COMPLETES $13.5 MILLION PRIVATE FINANCING
OXFORD GLYCOSYSTEMS INTRODUCES NEW PRODUCT TO SEQUENCE CARBOHYDRATES QUICKLY, EASILY; TWO COMPANION PRODUCTS ALSO DEVELOPED
IGG INTERNATIONAL TRADING ON THE PUBLIC MARKET THROUGH A REVERSE MERGER
IGG INTERNATIONAL, INC. ANNOUNCES A LICENSE AGREEMENT WITH THE GOVERNMENT OF ISRAEL
OXFORD MOLECULAR GROUP ANNOUNCES COLLABORATIVE RESEARCH AGREEMENT WITH YAMANOUCHI PHARMACEUTICAL
OXFORD MOLECULAR GROUP COMPLETES UNICHEM SOFTWARE AND TECHNOLOGY ACQUISITION FROM CRAY RESEARCH, INC.
IGG International Acquires Exclusive License to Agrogene Ltd. Carbohydrate Compounds
OGT Files Patent Infringement Suits Against Affymetrix In UK and US.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters